Literature DB >> 14676648

Blood pressure and outcome after severe pediatric traumatic brain injury.

Monica S Vavilala1, Anna Bowen, Arthur M Lam, Joshua C Uffman, Jeffrey Powell, H Richard Winn, Frederick P Rivara.   

Abstract

BACKGROUND: The relationship between systolic blood pressure and outcome in children after severe traumatic brain injury (TBI) is unclear. We examined the relationship between age-appropriate systolic blood pressure (AASBP) percentile and outcome after severe pediatric TBI.
METHODS: We examined the association between AASBP percentiles and outcome in 172 children younger than 14 years of age with a Glasgow Coma Scale score < 9. Outcome was evaluated using discharge Glasgow Outcome Scale score. Poor outcome was defined as a Glasgow Outcome Scale score < 4.
RESULTS: Poor outcome was associated with AASBP < 75th percentile (odds ratio, 4.2; 95% confidence interval, 2.1-8.3). Patients with systolic blood pressure (SBP) > or = 90 mm Hg and AASBP < 75th percentile had a higher odds for poor outcome compared with patients with SBP > or = 90 mm Hg and AASBP > or = 75th percentile (odds ratio, 3.5; 95% confidence interval, 1.7-7.3). CONCLUSION AASBP < 75th percentile was associated with poor outcome after severe pediatric TBI, even when SBP was > or = 90 mm Hg.

Entities:  

Mesh:

Year:  2003        PMID: 14676648     DOI: 10.1097/01.TA.0000101759.23607.57

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  24 in total

Review 1.  Pediatric neurocritical care.

Authors:  Sarah Murphy
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Diffusion tensor imaging analysis of frontal lobes in pediatric traumatic brain injury.

Authors:  Margaret B Oni; Elisabeth A Wilde; Erin D Bigler; Stephen R McCauley; Trevor C Wu; Ragini Yallampalli; Zili Chu; Xiaoqi Li; Jill V Hunter; Ana C Vasquez; Harvey S Levin
Journal:  J Child Neurol       Date:  2010-03-23       Impact factor: 1.987

3.  Cerebral hemodynamic predictors of poor 6-month Glasgow Outcome Score in severe pediatric traumatic brain injury.

Authors:  Onuma Chaiwat; Deepak Sharma; Yuthana Udomphorn; William M Armstead; Monica S Vavilala
Journal:  J Neurotrauma       Date:  2009-05       Impact factor: 5.269

4.  Improving Understanding and Outcomes of Traumatic Brain Injury Using Bidirectional Translational Research.

Authors:  William M Armstead; Monica S Vavilala
Journal:  J Neurotrauma       Date:  2019-06-13       Impact factor: 5.269

5.  Fentanyl and Midazolam Are Ineffective in Reducing Episodic Intracranial Hypertension in Severe Pediatric Traumatic Brain Injury.

Authors:  Timothy P Welch; Michael J Wallendorf; Evan D Kharasch; Jeffrey R Leonard; Allan Doctor; Jose A Pineda
Journal:  Crit Care Med       Date:  2016-04       Impact factor: 7.598

6.  Emergency Neurological Life Support: Severe Traumatic Brain Injury.

Authors:  Rachel Garvin; Halinder S Mangat
Journal:  Neurocrit Care       Date:  2017-09       Impact factor: 3.210

Review 7.  Emergency Neurological Life Support: Traumatic Brain Injury.

Authors:  Rachel Garvin; Chitra Venkatasubramanian; Angela Lumba-Brown; Chad M Miller
Journal:  Neurocrit Care       Date:  2015-12       Impact factor: 3.210

Review 8.  Update on the 2012 guidelines for the management of pediatric traumatic brain injury - information for the anesthesiologist.

Authors:  Nina Hardcastle; Hubert A Benzon; Monica S Vavilala
Journal:  Paediatr Anaesth       Date:  2014-05-12       Impact factor: 2.556

9.  Variation in cerebral blood flow velocity with cerebral perfusion pressure >40 mm Hg in 42 children with severe traumatic brain injury.

Authors:  Shaji Philip; Onuma Chaiwat; Yuthana Udomphorn; Anne Moore; Jerry J Zimmerman; William Armstead; Monica S Vavilala
Journal:  Crit Care Med       Date:  2009-11       Impact factor: 7.598

Review 10.  Cerebral blood flow and autoregulation after pediatric traumatic brain injury.

Authors:  Yuthana Udomphorn; William M Armstead; Monica S Vavilala
Journal:  Pediatr Neurol       Date:  2008-04       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.